Literature DB >> 16133722

The spectrum of differential diagnosis in neurological patients with livedo reticularis and livedo racemosa. A literature review.

Markus Kraemer1, Dieter Linden, Peter Berlit.   

Abstract

Livedo is a cutaneous sign of striking violaceous netlike patterned erythema of the skin. This dermatological phenomenon is of special interest in the differential diagnosis in neurological patients. In 1907 Ehrmann distinguished two different patterns of livedo: the pathological livedo racemosa and the physiological livedo reticularis. Despite important clinical differences, in the English language literature the heading livedo reticularis is still used for all types of livedo. A literature review about the spectrum of differential diagnosis in patients with livedo reticularis (especially cutis marmorata and amantadine-induced livedo reticularis) and livedo racemosa (especially Sneddon's syndrome, Divry-van Bogaert syndrome, systemic lupus erythematosus, antiphospholipid antibody syndrome, polyarteritis nodosa, cholesterol embolization syndrome, livedoid vasculopathy and haematological diseases) is provided.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16133722     DOI: 10.1007/s00415-005-0967-9

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  105 in total

1.  Classification of vasculitis.

Authors:  J C Piette; C Fieschi; Z Amoura
Journal:  N Engl J Med       Date:  1999-12-02       Impact factor: 91.245

2.  Livedo vasculitis with protein C system deficiency.

Authors:  M Baccard; M D Vignon-Pennamen; M Janier; M L Scrobohaci; L Dubertret
Journal:  Arch Dermatol       Date:  1992-10

3.  Amantadine in parkinsonian patients unresponsive to levodopa: a pilot study.

Authors:  C Colosimo; M Merello; F E Pontieri
Journal:  J Neurol       Date:  1996-05       Impact factor: 4.849

4.  [Divry-Van Bogaert cortico-meningeal angiomatosis and Sneddon's syndrome. Nosological study. Apropos of 4 cases].

Authors:  E Ellie; J Julien; P Henry; C Vital; X Ferrer
Journal:  Rev Neurol (Paris)       Date:  1987       Impact factor: 2.607

5.  Livedo reticularis and purpura: presenting features in fulminant pneumococcal septicemia in an asplenic patient.

Authors:  P A Rusonis; H N Robinson; S I Lamberg
Journal:  J Am Acad Dermatol       Date:  1986-11       Impact factor: 11.527

6.  Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients.

Authors:  M Gayraud; L Guillevin; P le Toumelin; P Cohen; F Lhote; P Casassus; B Jarrousse
Journal:  Arthritis Rheum       Date:  2001-03

7.  Livedo reticularis and Raynaud's phenomenon associated with cryoglobulinaemia but not related to hepatitis C virus in an HIV-1-positive patient.

Authors:  M A Muñoz-Pérez; A Rodriguez-Pichardo; F Camacho; M A Colmenero
Journal:  Eur J Dermatol       Date:  1998 Jul-Aug       Impact factor: 3.328

8.  The incidence and risk factors of cholesterol embolization syndrome, a complication of cardiac catheterization: a prospective study.

Authors:  Yoshihiro Fukumoto; Hiroyuki Tsutsui; Miyuki Tsuchihashi; Akihiro Masumoto; Akira Takeshita
Journal:  J Am Coll Cardiol       Date:  2003-07-16       Impact factor: 24.094

9.  Factor V Leiden mutation in Sneddon syndrome.

Authors:  R Besnier; C Francès; A Ankri; M Aiach; J C Piette
Journal:  Lupus       Date:  2003       Impact factor: 2.911

10.  Cutaneous manifestations in patients with essential thrombocythemia.

Authors:  P H Itin; R K Winkelmann
Journal:  J Am Acad Dermatol       Date:  1991-01       Impact factor: 11.527

View more
  17 in total

1.  Livedo reticularis and related disorders.

Authors:  Steven M Dean
Journal:  Curr Treat Options Cardiovasc Med       Date:  2011-04

2.  Primary central nervous system vasculitis and moyamoya disease: similarities and differences.

Authors:  Markus Kraemer; Peter Berlit
Journal:  J Neurol       Date:  2010-05       Impact factor: 4.849

Review 3.  Cerebral vasculitis in adults: what are the steps in order to establish the diagnosis? Red flags and pitfalls.

Authors:  P Berlit; M Kraemer
Journal:  Clin Exp Immunol       Date:  2014-03       Impact factor: 4.330

4.  Livedo reticularis heralding hypercalcaemia of malignancy.

Authors:  Deepak Sundriyal; Naveen Kumar; Gaurav Kumar; Meenu Walia
Journal:  BMJ Case Rep       Date:  2014-05-15

Review 5.  The clinical significance of antiphospholipid antibodies in systemic lupus erythematosus.

Authors:  Ozan Ünlü; Stephane Zuily; Doruk Erkan
Journal:  Eur J Rheumatol       Date:  2015-12-29

Review 6.  Heritable and non-heritable uncommon causes of stroke.

Authors:  A Bersano; M Kraemer; A Burlina; M Mancuso; J Finsterer; S Sacco; C Salvarani; L Caputi; H Chabriat; S Lesnik Oberstein; A Federico; E Tournier Lasserve; D Hunt; M Dichgans; M Arnold; S Debette; H S Markus
Journal:  J Neurol       Date:  2020-04-21       Impact factor: 4.849

Review 7.  Sneddon syndrome: under diagnosed disease, complex clinical manifestations and challenging diagnosis. A case-based review.

Authors:  Steve S Kong; Azin Azarfar; Neha Bhanusali
Journal:  Rheumatol Int       Date:  2020-06-12       Impact factor: 2.631

8.  Primary central nervous system vasculitis: clinical experiences with 21 new European cases.

Authors:  Markus Kraemer; Peter Berlit
Journal:  Rheumatol Int       Date:  2009-12-19       Impact factor: 2.631

9.  Primary antiphospholipid syndrome with and without Sneddon's syndrome.

Authors:  Cezar Augusto Muniz Caldas; Jozélio Freire de Carvalho
Journal:  Rheumatol Int       Date:  2009-12-12       Impact factor: 2.631

Review 10.  Livedo reticularis as a criterion for antiphospholipid syndrome.

Authors:  E Toubi; Y Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2007-04       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.